Probably someone at the conference. The TO is for warrant holders, so any new investors they are talking to now will need to purchase open market (unlike the past where these were used to promote off market purchases)... more of these conferences please. Remember unto leronlimab is approved, they are limited in how they can promote the drug. I’ve not listened yet, but nice purchase.